Bilateral Pallidal Deep Brain Stimulation Controls Dystonia in X-Linked Dystonia-Parkinsonism
Investigators examine the long-term outcomes of pallidal deep brain stimulation in x-linked dystonia-parkinsonism.
Investigators examine the long-term outcomes of pallidal deep brain stimulation in x-linked dystonia-parkinsonism.
In patients with Parkinson disease psychosis, treatment with pimavanserin has a lower risk for mortality compared with quetiapine or combination therapy.
The European Headache Federation has issued recommendations on how to best diagnose and treat idiopathic intracranial hypertension.
The novel questionnaire may identify patients with ALS suffering from dyspnea and allow early assessment and monitoring for symptom management.
Lasmiditan was found to be more effective compared with placebo in eliminating pain and other symptoms associated with headache in individuals with migraine.
Investigators examined the involvement of depression and anxiety on cognition and falls in patients with multiple sclerosis.
Investigators sought to determine whether subthalamic nucleus deep brain stimulation could influence clinical outcomes in patients with Parkinson disease.
A cerebrospinal fluid Aβ level may be a predictive biomarker for multiple sclerosis progression.
The Apathy Evaluation Scale was shorted to two-thirds of the original length and investigators evaluated the validity in Parkinson disease.
Investigators examine identifiers to predict disability in patients with relapsing-onset multiple sclerosis.